# Acrostak (Schweiz) AG – FDA Inspection, Jun 15, 2023

Source: https://www.keypedia.com/records/fda_inspections/acrostak-schweiz-ag/2d6c90e3-b69d-4eb9-9cc6-502bc03bd002
Source feed: FDA_Inspections

> FDA inspection 1208297 of Acrostak (Schweiz) AG, June 15, 2023. Classification: Official Action Indicated (OAI). 12 citations under 21 CFR part 820. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1208297
- Company Name: Acrostak (Schweiz) AG
- Inspection Date: 2023-06-15
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Postmarket Assurance: Devices
- Product Type: Devices
- Center: Medical Devices & Rad Health
- Office Name: Center for Devices and Radiological Health
- Citation Count: 12

## Related Documents

- FDA Inspection 1084171 - 2019-01-24

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/thomas-a-peter/48a36892-cc03-42bb-8960-978d18f2147a)

Company: https://www.keypedia.com/companies/acrostak-schweiz-ag/2daa683c-9c38-4e2b-a4c1-cd368a090598

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7
